RESOURCES FOR YOU AND YOUR PATIENTS
EUROPEAN MEDICAL JOURNAL SUMMARIES
Prof. Pavlov EMJ webinar summary
Read the key points from Prof. Pavlov presentation at the EMJ webinar
RWE in current MAFLD landscape
Find out what your peers use in their daily clinical practice to diagnose and treat MAFLD
Essential Phospholipids (EPL) in MAFLD
Learn how your peers use EPLs in the MAFLD continuum
MAFLD and metabolic comorbidities
Discover what other HCPs think are the risk factors associated to MAFLD
METABOLIC-ASSOCIATED FATTY LIVER DISEASE (MAFLD) & DIAGNOSIS
MAFLD burden and Ultrasound importance
Find out how MAFLD has an impact on healthcare resources and why it should be treated
Guidelines
Discover why the recent guidelines recommend ultrasound for MAFLD diagnosis
PATIENT CASES
Maria - Metabolic Syndrome patient
Learn about the most common profiles of patients with MAFLD
Sergei - Ischemic heart disease patient
Learn about the most common profiles of patients with MAFLD
Valentina - Type 2 diabetes patient
Learn about the most common profiles of patients with MAFLD
ESSENTIAL PHOSPHOLIPIDS (EPL) EVIDENCE
Prof Pavlov MAFLD & Comorbidities video
Find out more about results Manpower study from Professor Pavlov
Prof Pavlov Liver Structure improvement shown by ultrasound video
Find out more about how EPL treatment improved liver structure in Manpower study
Prof Pavlov Improvement of lipid profile
Find out more about how EPL treatment improved lipid profile in MAFLD patients shown in Manpower study
Prof Pavlov Improvement of enzyme levels
Find out more about how EPL treatment improved enzyme levels in MAFLD patients shown in Manpower study
Essentiale Manpower 3 Explainer Video
Watch this video to learn results of Manpower real world data study
Essentiale Manpower 2 Explainer Video
Watch this video to learn results of Manpower real world data study
EPLs vs competitors
Explore how efficacy and safety of Essential Phospholipids compare to other Treatment Options
MOA
Learn how Essential Phospholipids work and why they reduce steatosis
Prof Dajani open label study
Read the summary of a randomized open label study of EPL added to the treatment of primary MAFLD
Open label study of EPL outcomes
Watch Prof. Dajani explaining the outcomes of a randomized open label study of EPL added to the treatment of primary MAFLD
MANPOWER study 1
Find out how many patients with Diabetes, Metabolic syndrome and hypertension have MAFLD in this Real-World Evidence study in Russia
MANPOWER study 1
Download the slides to learn the prevalence of MAFLD in patients with diabetes, hypertension and metabolic syndrome.
MANPOWER study 1
Watch this video to learn how many patients with Diabetes, Metabolic syndrome and hypertension have MAFLD in this Real-World Evidence study in Russia
MAFLD in Focus
Unveiling Insights from China's RELIEF Study; Insight from APASL 2024
Shedding light on genomic, metabolic, and phenotypic effects of essential phospholipids on HepaRG
By Professor Paola Luciani
